Phase III study of Vinflunine plus Capecitabine versus Capecitabine alone in patients with advanced breast cancer
Phase III study of Vinflunine plus Capecitabine versus Capecitabine alone in patients with advanced breast cancer
Phase III study of Vinflunine plus Capecitabine versus Capecitabine alone in patients with advanced breast cancer
Status
Status :
Completed
Type of study
Phase III
Min. Age
21
Years old
Max. Age
80
Years old
Gender
Female
Therapeutic area :
Oncology
Disease :
Breast cancer
Study medication :
Vinflunine (Javlor®)
Phase :
Phase III
Start Date :
September 2013
End date :
July 2017
Study ID :
L00070 IN 311 BO
CT.gov Number :
NCT01953003
Send by email